TGF-β receptors: In and beyond TGF-β signaling

Alexandra Vander Ark1, Jingchen Cao1, Xiaohong Li1

  • 1Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, MI, 49503, USA.

Cellular Signalling
|September 6, 2018
PubMed

Insights

Transforming growth factor beta (TGF-β) signaling is crucial for development and homeostasis. Dysregulation of TGF-β receptors (TGFBRs) contributes to diseases like cancer, highlighting their complex roles.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • Transforming growth factor beta (TGF-β) is vital for cellular processes and homeostasis.
  • Aberrant TGF-β signaling is implicated in cancer initiation, progression, and metastasis.
  • TGF-β ligands interact with TGF-β receptors (TGFBRs), which mediate diverse cellular responses.

Purpose of the Study:

  • To review the multifaceted roles of TGF-β receptors (TGFBRs) in TGF-β signaling and beyond.
  • To explore the membrane trafficking, kinase activities, and interactions of TGFBRs.
  • To highlight novel functions and context-dependent regulation of TGF-β signaling via its receptors.

Main Methods:

  • Literature review focusing on TGFBR membrane trafficking.
  • Analysis of kinase activities of TGFBR1 and TGFBR2.
  • Examination of TGFBR2 interactions with other receptors and novel TGFBR3 roles.

Main Results:

  • TGFBRs exhibit distinct affinities for TGF-β ligands and possess varying kinase activities (TGFBR1 and 2 are kinases, TGFBR3 is not).
  • TGFBRs are essential for canonical and noncanonical signaling pathways and regulate other signaling networks.
  • TGF-β signaling effects are context-dependent, modulated by receptor and ligand regulation.

Conclusions:

  • TGF-β receptors are central regulators of TGF-β signaling with critical roles in development and disease.
  • Understanding TGFBR trafficking, kinase activity, and interactions is key to deciphering TGF-β's context-dependent functions.
  • Novel roles of TGFBR3 and receptor interactions offer new therapeutic targets for TGF-β-related pathologies.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.8K
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.2K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.8K
Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers01:25

Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers

β-adrenergic antagonists, or β-blockers, modulate the sympathetic nervous system by targeting β-adrenoceptors and inhibiting catecholamine-mediated sympathetic responses. β-blockers differ in their adrenoceptor subtype affinity, lipophilicity, and α-blocking capabilities. The history of β-blocker development began with the prototype, dichloroisoprenaline, which exhibited partial agonist activity. As a result, propranolol was developed as a pure antagonist but...
1.5K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.6K